Fixed-Ratio Combination of Insulin and GLP-1 RA in Patients with Longstanding Type 2 Diabetes: A Subanalysis of LixiLan-L

INTRODUCTION: With longer duration and progression of type 2 diabetes (T2D), β-cell function deteriorates and insulin therapy often becomes necessary. Glucagon-like peptide-1 receptor agonists such as lixisenatide that do not rely only on β-cell function and glucagon suppression primarily, but also...

Descripción completa

Detalles Bibliográficos
Autores principales: Blonde, Lawrence, Berard, Lori, Saremi, Aramesh, Huang, Yao, Aroda, Vanita R., Raccah, Denis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136373/
https://www.ncbi.nlm.nih.gov/pubmed/32166620
http://dx.doi.org/10.1007/s13300-020-00797-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136373/
https://www.ncbi.nlm.nih.gov/pubmed/32166620
http://dx.doi.org/10.1007/s13300-020-00797-y

Ejemplares similares